MSB 3.36% $1.15 mesoblast limited

DREAM HF Trial Video, page-24

  1. 12,206 Posts.
    lightbulb Created with Sketch. 1085
    The Phase 3 trial results will be considered pivotal to support regulatory approval in the United States, as well as in China through a partnership with Tasly Pharmaceuticals to develop and commercialize the product for advanced chronic heart failure.

    Mesoblast Website

    The Chinese market fairly sizeable .


    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
-0.040(3.36%)
Mkt cap ! $1.370B
Open High Low Value Volume
$1.18 $1.22 $1.15 $3.982M 3.371M

Buyers (Bids)

No. Vol. Price($)
16 71292 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 21383 3
View Market Depth
Last trade - 12.53pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.